about
Ethnic differences in cancer incidence: a marker for inherited susceptibility?The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer.Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityStudy of a single BRCA2 mutation with high carrier frequency in a small populationA high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer familiesPopulation-Calibrated Gene Characterization: Estimating Age at Onset Distributions Associated With Cancer GenesAssociation of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer RiskEstimation of tumor heterogeneity using CGH array data.The genetic basis of breast cancer and its clinical implications.Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.Tumor suppressor genes and breast cancer.BRCA1 and BRCA2 in breast cancer.BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.Prophylactic mastectomy and inherited predisposition to breast carcinoma.Managing hereditary ovarian cancer risk.Genetic predisposition to breast cancer: a surgical perspective.Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.Prophylactic oophorectomy: clinical considerations.Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.Missense mutations in disease genes: a Bayesian approach to evaluate causality.A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiersScreening for ovarian cancer: recommendation statement.The prevention of breast cancer.BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer GroupHigh frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjectsConcerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.The role of magnetic resonance imaging in diagnosis and management of breast cancer.Age and Geographical Distribution in Families with BRCA1/BRCA2 Mutations in the Slovak Republic.Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancerMorphological and molecular basis of ovarian serous carcinoma.The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets.Genomic Biomarkers for Breast Cancer Risk.MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls.Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas.The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.Living With Genetic Vulnerability: a Life Course Perspective.Predictive genetic tests: problems and pitfalls.
P2860
Q23923048-E2AE8485-39A8-4FBF-8D3C-F69F0D219383Q24311419-2B1B89AF-AB19-45FB-AEFD-F5E2E3C5E090Q24679438-BEE0F19E-B309-4AC8-AD48-B6385889F05EQ24680535-078A2595-3A2F-450F-B3B7-2A7A4BBF9F81Q24680760-78A1FC67-0A61-4FED-9B66-5D9EB6132B2AQ28383948-7BDACFDE-B1CF-44AE-AA66-9193C6C08D14Q28396126-A21DAF3A-AF56-41FD-9BDA-BEE83B801307Q33398782-C55D9EA9-C4A7-48AF-908B-8CC51AA2741FQ33536033-4EAEC4C6-1228-4DB7-ABDC-BB17B7E438D6Q33597528-4182AAE7-FACB-4AA2-98D0-5F9E032EFB10Q33638362-E32BCBE2-46B6-45D8-920E-FA06C6914031Q33658723-9F27C836-B440-4FF8-B92A-09B47CFB65ACQ33679850-FD188804-C3EF-45E3-8C85-A3B5F09BB184Q33813985-39AE92E3-D9FF-48AD-8570-B3561189B680Q33813990-354FE454-2EE9-412E-B0A4-C08E161A3D48Q33836065-A16772DA-238F-4BF6-A93E-34D10EF87FD2Q33955566-AEE99606-7C9F-4D36-939D-942A96D694D4Q33959816-C2FB984F-0840-46E9-9D27-B134E2F145E5Q33964990-5FE10EFE-9F3C-47D3-81EC-149BC8FF323BQ34146408-1D464B8F-38AC-4797-8CCE-CAABD81F0552Q34385706-7C4F88B0-9D61-4E54-BA1C-B94AFF670CE5Q34411614-780C86B8-EB70-41D5-8E2D-66700D64ED90Q34628501-1E3E9DDC-21F1-4A8C-BA23-70CD7CD682BDQ35174922-F8EBB680-3CEB-4F38-B4E4-FC6586960AAAQ35238484-F211C9F1-235C-4C44-9B26-A63FEB162F50Q35432260-01303B1D-BCAC-4024-8F1A-6BCFD1AA5580Q35563836-5154D151-F4F5-49F1-A540-2F14EA454133Q35961071-4E31DC8A-33C6-4E34-8A0F-CC61B7A5F25CQ36108177-571A729C-F077-40C6-894C-1C7395A74153Q36620670-15E84219-CB9E-4864-A4FD-0A3A0FE2DA3DQ36681565-436D74EA-F1B5-4EC6-B6E9-17262A54B4F2Q37079442-EB6DE972-D16C-4A0B-95F0-6BA332D0822EQ37242239-A5EC66E7-3C31-4A18-88DB-1066462A3A0AQ37582766-012E29A1-D0D9-4794-B98F-F38010134048Q37709882-7DCC256F-D349-45D3-B273-2EA4EEF9CE38Q38440084-B2E9EB26-91DF-4DDE-A23E-E2C8506310EDQ38842957-A2628EE1-3866-4EB4-9457-EF207BF51993Q39080898-12F5A04F-2DB4-4FFF-B0BF-18709E65376CQ40590078-0C59542D-6B92-40D6-BAD2-E0E456F24FCEQ40856273-E0DA20D3-15DD-4F5B-B57C-1BF42AC5D010
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The genetics of breast and ovarian cancer
@ast
The genetics of breast and ovarian cancer
@en
type
label
The genetics of breast and ovarian cancer
@ast
The genetics of breast and ovarian cancer
@en
prefLabel
The genetics of breast and ovarian cancer
@ast
The genetics of breast and ovarian cancer
@en
P2860
P921
P356
P1476
The genetics of breast and ovarian cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1995.417
P407
P577
1995-10-01T00:00:00Z
P5875
P6179
1005396893